[High expression of apolipoprotein C1 promotes proliferation and inhibits apoptosis of papillary thyroid carcinoma cells by activating the JAK2/STAT3 signaling pathway]
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Apolipoprotein C1 (APOC1) is upregulated in papillary thyroid carcinoma (PTC), promoting cell proliferation and inhibiting apoptosis. APOC1 activates the JAK2/STAT3 pathway, driving PTC progression.
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Context
- Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer.
- Understanding the molecular mechanisms underlying PTC progression is crucial for developing targeted therapies.
Purpose
- To investigate the expression of apolipoprotein C1 (APOC1) in PTC tissues and cell lines.
- To elucidate the role of APOC1 in regulating PTC cell proliferation, apoptosis, and cell cycle.
- To explore the involvement of the JAK2/STAT3 signaling pathway in APOC1-mediated effects.
Summary
- APOC1 expression is significantly elevated in PTC tissues and cell lines compared to normal controls.
- APOC1 knockdown suppresses PTC cell proliferation, induces apoptosis, and arrests the cell cycle at G0/G1 phase.
- APOC1 overexpression exhibits opposite effects, promoting proliferation and inhibiting apoptosis by activating the JAK2/STAT3 pathway.
Impact
- This study identifies APOC1 as a potential oncogene in PTC.
- Targeting APOC1 or the JAK2/STAT3 pathway may offer novel therapeutic strategies for PTC treatment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...